share_log

Trustmark Analyst Ratings

Trustmark Analyst Ratings

信任標誌分析師評級
Benzinga ·  2023/09/27 12:30
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/27/2023 9.52% Truist Securities $25 → $23 Maintains Hold
07/27/2023 33.33% Keefe, Bruyette & Woods $26 → $28 Maintains Market Perform
06/29/2023 14.29% Truist Securities $27 → $24 Maintains Hold
04/28/2023 28.57% Truist Securities $28 → $27 Maintains Hold
04/06/2023 33.33% Keefe, Bruyette & Woods $30 → $28 Maintains Market Perform
04/06/2023 Raymond James Downgrades Outperform → Market Perform
02/21/2023 61.9% Raymond James → $34 Upgrades Market Perform → Outperform
02/01/2023 42.86% Truist Securities $37 → $30 Maintains Hold
01/26/2023 47.62% Piper Sandler $36 → $31 Maintains Neutral
01/09/2023 80.95% DA Davidson → $38 Initiates Coverage On → Neutral
10/29/2020 23.81% Piper Sandler $25 → $26 Maintains Neutral
09/30/2020 19.05% Piper Sandler $27 → $25 Maintains Neutral
07/30/2020 Raymond James Upgrades Underperform → Market Perform
01/02/2020 71.43% SunTrust Robinson Humphrey $37 → $36 Maintains Hold
03/20/2019 Keefe, Bruyette & Woods Downgrades Market Perform → Underperform
01/07/2019 Raymond James Downgrades Market Perform → Underperform
10/29/2018 47.62% SunTrust Robinson Humphrey $36 → $31 Maintains Hold
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
09/27/2023 9.52% Truist證券 $25→$23 維護 保持
07/27/2023 33.33% Keefe,Bruyette&Wood $26→$28 維護 市場表現
2023年6月29日 14.29% Truist證券 $27→$24 維護 保持
04/28/2023 28.57% Truist證券 $28→$27 維護 保持
04/06/2023 33.33% Keefe,Bruyette&Wood $30→$28 維護 市場表現
04/06/2023 - 雷蒙德·詹姆斯 評級下調 跑贏→市場表現
02/21/2023 61.9% 雷蒙德·詹姆斯 →$34 升級 市場表現優於→
02/01/2023 42.86% Truist證券 $37→$30 維護 保持
2023年1月26日 47.62% 派珀·桑德勒 $36→$31 維護 中性
01/09/2023 80.95% 達·戴維森 →$38 開始承保 →中性
10/29/2020 23.81% 派珀·桑德勒 $25→$26 維護 中性
09/30/2020 19.05% 派珀·桑德勒 $27→$25 維護 中性
07/30/2020 - 雷蒙德·詹姆斯 升級 表現遜於→市場表現
1/02/2020 71.43% SunTrust Robinson Humphrey $37→$36 維護 保持
2019/03/20 - Keefe,Bruyette&Wood 評級下調 市場表現→表現不佳
2019年07月01日 - 雷蒙德·詹姆斯 評級下調 市場表現→表現不佳
2018年10月29日 47.62% SunTrust Robinson Humphrey $36→$31 維護 保持

What is the target price for Trustmark (TRMK)?

Trustmark(TRMK)的目標價是多少?

The latest price target for Trustmark (NASDAQ: TRMK) was reported by Truist Securities on September 27, 2023. The analyst firm set a price target for $23.00 expecting TRMK to rise to within 12 months (a possible 9.52% upside). 10 analyst firms have reported ratings in the last year.

Trustmark(納斯達克:TRMK)的最新目標價是由Truist Securities於2023年9月27日報道的。這家分析公司將目標價定為23.00美元,預計TRMK將在12個月內上漲(可能上漲9.52%)。去年有10家分析公司公佈了評級。

What is the most recent analyst rating for Trustmark (TRMK)?

Trustmark(TRMK)的最新分析師評級是多少?

The latest analyst rating for Trustmark (NASDAQ: TRMK) was provided by Truist Securities, and Trustmark maintained their hold rating.

Trustmark(納斯達克代碼:TRMK)的最新分析師評級由Truist Securities提供,Trustmark維持其持有評級。

When is the next analyst rating going to be posted or updated for Trustmark (TRMK)?

Trustmark(TRMK)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Trustmark, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Trustmark was filed on September 27, 2023 so you should expect the next rating to be made available sometime around September 27, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公開財務報表,與Trustmark的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Trustmark的上一次評級是在2023年9月27日提交的,因此您應該預計下一次評級將在2024年9月27日左右提供。

Is the Analyst Rating Trustmark (TRMK) correct?

分析師評級Trustmark(TRMK)正確嗎?

While ratings are subjective and will change, the latest Trustmark (TRMK) rating was a maintained with a price target of $25.00 to $23.00. The current price Trustmark (TRMK) is trading at is $21.00, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Trustmark(TRMK)評級維持不變,目標價在25.00美元至23.00美元之間。Trustmark(TRMK)目前的交易價格為21.00美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論